Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 190(12): 6681-93, 2013 Jun 15.
Article in English | MEDLINE | ID: mdl-23686488

ABSTRACT

The microenvironment of human follicular lymphoma (FL), an incurable B cell non-Hodgkin's lymphoma, is thought to play a major role in its pathogenesis and course. Microenvironmental cells of likely importance include follicular Th cells (TFH) and regulatory T cells (Tregs), and understanding their interactions with FL tumor cells is necessary to develop novel therapeutic strategies. We found that IL-4 and CD40L are expressed by intratumoral TFH and induce production of CCL17 and CCL22 by FL tumor cells. IL-4 alone induces only CCL17 but enhances stimulation by CD40L of both CCL17 and CCL22. Consistent with our in vitro results, mRNA transcripts of IL-4 correlated with CCL17, but not CCL22, in gene expression profiling studies of FL biopsies, whereas CD40L correlated with both CCL17 and CCL22. Tumor supernatants induced preferential migration of Tregs and IL-4-producing T cells rather than IFN-γ-producing T cells, and Abs to CCR4 significantly abrogated the migration of Tregs. Our results suggest that through two distinct mechanisms, intratumoral TFH induce production of CCL17 and CCL22 by FL tumor cells and facilitate active recruitment of Tregs and IL-4-producing T cells, which, in turn, may stimulate more chemokine production in a feed-forward cycle. Thus, TFH appear to play a major role in generating an immunosuppressive tumor microenvironment that promotes immune escape and tumor survival and growth. Our results provide novel insights into the cross talk among TFH, tumor cells, and Tregs in FL, and offer potential targets for development of therapeutic strategies to overcome immune evasion.


Subject(s)
Lymphoma, Follicular/immunology , Receptor Cross-Talk/immunology , T-Lymphocytes, Helper-Inducer/immunology , Tumor Escape/immunology , Tumor Microenvironment/immunology , Blotting, Western , Cell Separation , Chemokine CCL17/immunology , Chemokine CCL17/metabolism , Chemokine CCL22/immunology , Chemokine CCL22/metabolism , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Gene Knockdown Techniques , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Lymphoma, Follicular/metabolism , Lymphoma, Follicular/mortality , Oligonucleotide Array Sequence Analysis , RNA, Small Interfering , Real-Time Polymerase Chain Reaction
2.
J Immunol ; 190(9): 4887-98, 2013 May 01.
Article in English | MEDLINE | ID: mdl-23536634

ABSTRACT

Ag activation of the BCR may play a role in the pathogenesis of human follicular lymphoma (FL) and other B cell malignancies. However, the nature of the Ag(s) recognized by tumor BCRs has not been well studied. In this study, we used unbiased approaches to demonstrate that 42 (19.35%) of 217 tested FL Igs recognized vimentin as a shared autoantigen. The epitope was localized to the N-terminal region of vimentin for all vimentin-reactive tumor Igs. We confirmed specific binding to vimentin by using recombinant vimentin and by performing competitive inhibition studies. Furthermore, using indirect immunofluorescence staining, we showed that the vimentin-reactive tumor Igs colocalized with an anti-vimentin mAb in HEp-2 cells. The reactivity to N-terminal vimentin of IgG FL Igs was significantly higher than that of IgM FL Igs (30.4 versus 10%; p = 0.0022). However, vimentin-reactive FL Igs did not share CDR3 motifs and were not homologous. Vimentin was expressed in the T cell-rich regions of FL, suggesting that vimentin is available for binding with tumor BCRs within the tumor microenvironment. Vimentin was also frequently recognized by mantle cell lymphoma and multiple myeloma Igs. Our results demonstrate that vimentin is a shared autoantigen recognized by nonstereotyped FL BCRs and by the Igs of mantle cell lymphoma and multiple myeloma and suggest that vimentin may play a role in the pathogenesis of multiple B cell malignancies. These findings may lead to a better understanding of the biology and natural history of FL and other B cell malignancies.


Subject(s)
Autoantigens/immunology , Lymphoma, B-Cell/immunology , Receptors, Antigen, B-Cell/immunology , Vimentin/immunology , Amino Acid Sequence , Antibodies, Monoclonal/immunology , B-Lymphocytes/immunology , B-Lymphocytes/pathology , Cell Line, Tumor , Humans , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Lymphoma, B-Cell/pathology , Lymphoma, Follicular/immunology , Lymphoma, Follicular/pathology , Molecular Sequence Data , Multiple Myeloma/immunology , Multiple Myeloma/pathology , T-Lymphocytes/immunology , T-Lymphocytes/pathology
3.
Infect Immun ; 79(1): 75-87, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20956573

ABSTRACT

Although DNA repair proteins in bacteria are critical for pathogens' genome stability and for subverting the host defense, the role of host DNA repair proteins in response to bacterial infection is poorly defined. Here, we demonstrate, for the first time, that infection with the Gram-negative bacterium Pseudomonas aeruginosa significantly altered the expression and enzymatic activity of 8-oxoguanine DNA glycosylase (OGG1) in lung epithelial cells. Downregulation of OGG1 by a small interfering RNA strategy resulted in severe DNA damage and cell death. In addition, acetylation of OGG1 is required for host responses to bacterial genotoxicity, as mutations of OGG1 acetylation sites increased Cockayne syndrome group B (CSB) protein expression. These results also indicate that CSB may be involved in DNA repair activity during infection. Furthermore, OGG1 knockout mice exhibited increased lung injury after infection with P. aeruginosa, as demonstrated by higher myeloperoxidase activity and lipid peroxidation. Together, our studies indicate that P. aeruginosa infection induces significant DNA damage in host cells and that DNA repair proteins play a critical role in the host response to P. aeruginosa infection, serving as promising targets for the treatment of this condition and perhaps more broadly Gram-negative bacterial infections.


Subject(s)
DNA Repair/physiology , Epithelial Cells/metabolism , Lung/cytology , Pseudomonas Infections/immunology , Animals , Apoptosis , Cell Line , Cell Proliferation , DNA Damage , DNA Glycosylases/genetics , DNA Glycosylases/metabolism , Epithelial Cells/microbiology , Gene Expression Regulation/physiology , Humans , Lipid Peroxidation , Mice , Peroxidase , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa
4.
PLoS One ; 4(3): e4891, 2009.
Article in English | MEDLINE | ID: mdl-19305493

ABSTRACT

Although alveolar epithelial type II cells (AECII) perform substantial roles in the maintenance of alveolar integrity, the extent of their contributions to immune defense is poorly understood. Here, we demonstrate that AECII activates alveolar macrophages (AM) functions, such as phagocytosis using a conditioned medium from AECII infected by P. aeruginosa. AECII-derived chemokine MCP-1, a monocyte chemoattractant protein, was identified as a main factor in enhancing AM function. We proposed that the enhanced immune potency of AECII may play a critical role in alleviation of bacterial propagation and pneumonia. The ability of phagocytosis and superoxide release by AM was reduced by MCP-1 neutralizing antibodies. Furthermore, MCP-1(-/-) mice showed an increased bacterial burden under PAO1 and PAK infection vs. wt littermates. AM from MCP-1(-/-) mice also demonstrated less superoxide and impaired phagocytosis over the controls. In addition, AECII conditioned medium increased the host defense of airway in MCP-1(-/-) mice through the activation of AM function. Mechanistically, we found that Lyn mediated NFkappaB activation led to increased gene expression and secretion of MCP-1. Consequently Lyn(-/-) mice had reduced MCP-1 secretion and resulted in a decrease in superoxide and phagocytosis by AM. Collectively, our data indicate that AECII may serve as an immune booster for fighting bacterial infections, particularly in severe immunocompromised conditions.


Subject(s)
Epithelial Cells/immunology , Macrophages, Alveolar/immunology , Pseudomonas Infections/immunology , Pseudomonas aeruginosa/immunology , Respiratory Mucosa , Animals , Cells, Cultured , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Culture Media, Conditioned , Epithelial Cells/cytology , Epithelial Cells/microbiology , Female , Macrophages, Alveolar/cytology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , NF-kappa B/metabolism , Phagocytosis/physiology , Rats , Respiratory Mucosa/cytology , Respiratory Mucosa/immunology , src-Family Kinases/metabolism
5.
Curr Hematol Malig Rep ; 4(4): 189-95, 2009 Oct.
Article in English | MEDLINE | ID: mdl-20425407

ABSTRACT

Follicular lymphoma is one of the most immune-responsive cancers. The clonal tumor immunoglobulin expressed on the surface of malignant B cells, termed idiotype, has been used as a tumor-specific antigen in therapeutic vaccination strategies for follicular lymphoma and other B-cell malignancies. A number of phase 1 and phase 2 clinical trials have established the safety and immunogenicity of idiotype vaccine in follicular lymphoma. Three randomized, double-blind, controlled phase 3 clinical trials have recently been completed to definitively evaluate the clinical benefit of idiotype vaccine in follicular lymphoma. This review focuses on the results of these idiotype vaccine trials and discusses potential strategies to enhance the efficacy of vaccines in the future.


Subject(s)
Cancer Vaccines/immunology , Immunoglobulin Idiotypes/immunology , Lymphoma, Follicular/immunology , Cancer Vaccines/therapeutic use , Clinical Trials as Topic , Humans , Lymphoma, Follicular/prevention & control , Models, Immunological , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Treatment Outcome , Vaccination/methods
6.
J Immunol ; 180(4): 2396-408, 2008 Feb 15.
Article in English | MEDLINE | ID: mdl-18250449

ABSTRACT

The mechanism of phagocytosis of pathogens remains to be fully characterized. We report a novel phagocytosis pathway for Pseudomonas aeruginosa, which is initiated by cholesterol-rich membrane rafts and is dependent on Lyn, primarily an immune regulator with both positive and negative roles. Blocking of Lyn or blocking of cholesterol synthesis significantly inhibited phagocytosis by alveolar macrophages. We found that Lyn, via Src homology 2 and 3 domains, bound to and then activated PI3K and Akt to regulate intracellular routing of the engulfed P. aeruginosa. Further analysis indicates that Lyn and raft components entered in phagosomes and late lysosomes. Finally, respiratory burst was dependent on Lyn and membrane rafts, as confirmed by small interfering RNA and dominant-negative strategies. Our investigations demonstrate that Lyn along with membrane rafts plays a fundamental role in phagocytosis by alveolar macrophages during infection.


Subject(s)
Cholesterol/physiology , Membrane Microdomains/physiology , Phagocytosis , Pseudomonas Infections/metabolism , src-Family Kinases/physiology , Amino Acid Substitution/genetics , Animals , Cells, Cultured , Macrophages, Alveolar/enzymology , Macrophages, Alveolar/metabolism , Macrophages, Alveolar/microbiology , Membrane Microdomains/metabolism , Mice , Phagocytosis/genetics , Phagocytosis/immunology , Phagosomes/enzymology , Phagosomes/immunology , Phagosomes/metabolism , Pseudomonas Infections/enzymology , Pseudomonas Infections/immunology , Rats , Rats, Sprague-Dawley , Respiratory Burst/genetics , Respiratory Burst/immunology , Signal Transduction/genetics , Signal Transduction/immunology , src-Family Kinases/biosynthesis , src-Family Kinases/genetics
7.
Chem Res Toxicol ; 20(8): 1126-33, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17630705

ABSTRACT

Luminescent nanomaterials can provide high-intensity and photostable luminescent signals when used as labeling materials for the determination of trace amounts of analytes. However, a major concern that has arisen is whether the nanomaterials cause toxic effects in living systems. Here, we address this problem through a systematic investigation of the cytotoxicity and genotoxicity of luminescent silica nanoparticles. These nanoparticles are intensely luminescent labeling materials for ultrasensitive determination of biological samples. The investigation of genotoxicity of the nanomaterials was carried out from two perspectives. First, the integrity of the DNA was examined by detecting DNA base modification, strand breaks, and increased DNA repair activity to recover the damage. Second, different sets of cellular DNAs, including nuclear DNA extracts and the whole genomic DNAs, were examined. Furthermore, to fully assess DNA damage by the nanoparticles, isolated genomic DNAs were directly exposed to the nanoparticles. The cytotoxicity of the nanoparticle was detected by measuring the cell proliferation rate, cell death, and death patterns (necrosis and apoptosis) after the nanoparticle treatments. Results show no significant toxic effects due to the luminescent nanoparticles at the molecular and cellular levels below a concentration of 0.1 mg/mL. Our study indicates that the luminescent silica nanoparticle is a promising labeling reagent for various biomedical applications.


Subject(s)
Cell Proliferation/drug effects , DNA Damage/drug effects , Luminescence/adverse effects , Nanoparticles/toxicity , Silicon Dioxide/pharmacology , Animals , Cell Death/drug effects , Cells, Cultured , DNA Damage/physiology , Humans , Kinetics , Mutagenicity Tests , Nanoparticles/chemistry , Silicon Dioxide/chemistry
8.
Eur J Immunol ; 36(7): 1739-52, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16791881

ABSTRACT

Lyn is an important B cell signaling kinase of the Src tyrosine kinase family with a broad range of functions from cytoskeletal changes to induction of apoptosis. However, the role of Lyn in infectious diseases is not clear. Here, we demonstrate that Lyn activation by phosphorylation significantly impacted invasion of an alveolar epithelial cell line, primary lung cells, and rat lungs by Pseudomonas aeruginosa (PA), a common opportunistic lung pathogen affecting individuals with deficient lung immunity. Our results indicate that activation of Lyn and its interaction with rafts and TLR2, played an important role in the initial stages of PA interaction with host cells. The role of Lyn was further evaluated using the pharmacologic Src-specific inhibitor PP2, a dominant negative mutant, and finally confirmed with Lyn-deficient (Lyn(-/-)) bone marrow-derived mast cells. Inhibition of Lyn's function by above approaches prevented PA internalization. Moreover, blocking of Lyn also affected downstream events: induction of inflammatory cytokines and apoptosis. This report brings out a new role of Lyn in infectious diseases and indicates potential new targets for prevention and treatment of infections.


Subject(s)
Pseudomonas aeruginosa/immunology , Pulmonary Alveoli/enzymology , Pulmonary Alveoli/microbiology , src-Family Kinases/physiology , Animals , Cell Line, Tumor , Cells, Cultured , Epithelial Cells/cytology , Epithelial Cells/enzymology , Epithelial Cells/microbiology , Female , Humans , Membrane Microdomains/enzymology , Membrane Microdomains/microbiology , Pseudomonas Infections/enzymology , Pseudomonas Infections/immunology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/pathogenicity , Pulmonary Alveoli/cytology , Rats , Rats, Sprague-Dawley
9.
Curr Stem Cell Res Ther ; 1(1): 37-46, 2006 Jan.
Article in English | MEDLINE | ID: mdl-18220852

ABSTRACT

Recently, research of stem cells has garnered great attention and has shown promise by changing the view of traditional therapeutics, with broad impact on gene therapy, carcinogenesis, organ development, tissue injury, regeneration and almost all aspects of the life cycle and all living systems. A century's scientific progress has significantly improved controls for infectious diseases and many other disorders. However, many remaining problems (i.e. cancer, AIDS, diabetes, Parkinson's disease and Marburg infection) appear to be even harder than those that have already been solved. In particular, respiratory stem cell research has been less active and has moved more slowly than that of many other organs. This is probably due to the complexity of the lung and airway system, particularly owing to the many types of cells (>40), unique structures and functions, and technical difficulty in analyzing this system at the genetic, biochemical, molecular and cellular level. Compared with other epithelial cells (i.e., gastrointestinal epithelium), respiratory epithelia have a very low turnover rate and minimal regenerative activity. This review will discuss the current state of pulmonary stem cells, their origin, development, differentiation, and regenerative application, with a particular focus on potential impact on cancer development and lung injury repair.


Subject(s)
Respiratory Physiological Phenomena , Respiratory System/cytology , Animals , Bone Marrow Transplantation , Cell Differentiation , Epithelial Cells/cytology , Epithelial Cells/physiology , Genetic Therapy , Humans , Life Cycle Stages , Lung Neoplasms/therapy , Regeneration , Respiratory Tract Diseases/surgery , Respiratory Tract Diseases/therapy , Stem Cell Transplantation , Stem Cells/cytology , Stem Cells/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...